Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: Results of a randomized controlled trial

Hiroshi Imamura, Yukinori Kurokawa, Junji Kawada, Toshimasa Tsujinaka, Shuji Takiguchi, Yoshiyuki Fujiwara, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Bursectomy, a procedure dissecting the peritoneal lining covering the pancreas and the anterior plane of the transverse mesocolon, has been commonly performed with radical gastrectomy for gastric cancer patients. Although possibly improving the prognosis of gastric cancers, adverse events related to bursectomy should be evaluated in prospective studies. Methods: This prospective randomized controlled trial was conducted by experienced surgeons in 11 Japanese institutions. Patients with T2 or T3 gastric adenocarcinoma were intraoperatively randomized to radical gastrectomy plus D2 lymphadenectomy either with or without bursectomy. Postoperative morbidity and mortality were compared between the two groups. Results: A total of 210 patients were assigned to the bursectomy group (104 patients) and the nonbursectomy group (106 patients) between July 2002 and January 2007. Background characteristics were well balanced. Intraoperative blood loss was greater in the bursectomy group than in the nonbursectomy group (median 475 vs. 350 ml, p = 0.047), whereas other surgical factors did not vary significantly. The overall morbidity rate was 14.3% (30 patients), the same for the two groups. Likewise, the incidence of major postoperative complications, including pancreatic fistula, anastomotic leakage, abdominal abscess, bowel obstruction, hemorrhage, and pneumonia, were not significantly different between the two groups. The medians of the amylase level of the drainage fluid on postoperative day 1 were similar for the two groups (median 282 vs. 314 IU/L, p = 0.543). The hospital mortality rate was 0.95%: one patient per group. Conclusions: Experienced surgeons could safely perform a D2 gastrectomy with an additional bursectomy without increased major surgical complications.

Original languageEnglish
Pages (from-to)625-630
Number of pages6
JournalWorld journal of surgery
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 1 2011
Externally publishedYes

Fingerprint

Gastrectomy
Stomach Neoplasms
Randomized Controlled Trials
Morbidity
Mortality
Mesocolon
Abdominal Abscess
Pancreatic Fistula
Anastomotic Leak
Amylases
Hospital Mortality
Lymph Node Excision
Drainage
Pancreas
Pneumonia
Stomach
Adenocarcinoma
Prospective Studies
Hemorrhage
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer : Results of a randomized controlled trial. / Imamura, Hiroshi; Kurokawa, Yukinori; Kawada, Junji; Tsujinaka, Toshimasa; Takiguchi, Shuji; Fujiwara, Yoshiyuki; Mori, Masaki; Doki, Yuichiro.

In: World journal of surgery, Vol. 35, No. 3, 01.03.2011, p. 625-630.

Research output: Contribution to journalArticle

Imamura, Hiroshi ; Kurokawa, Yukinori ; Kawada, Junji ; Tsujinaka, Toshimasa ; Takiguchi, Shuji ; Fujiwara, Yoshiyuki ; Mori, Masaki ; Doki, Yuichiro. / Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer : Results of a randomized controlled trial. In: World journal of surgery. 2011 ; Vol. 35, No. 3. pp. 625-630.
@article{99a85a0c2d7b48bfb34870bef066c8b2,
title = "Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: Results of a randomized controlled trial",
abstract = "Background: Bursectomy, a procedure dissecting the peritoneal lining covering the pancreas and the anterior plane of the transverse mesocolon, has been commonly performed with radical gastrectomy for gastric cancer patients. Although possibly improving the prognosis of gastric cancers, adverse events related to bursectomy should be evaluated in prospective studies. Methods: This prospective randomized controlled trial was conducted by experienced surgeons in 11 Japanese institutions. Patients with T2 or T3 gastric adenocarcinoma were intraoperatively randomized to radical gastrectomy plus D2 lymphadenectomy either with or without bursectomy. Postoperative morbidity and mortality were compared between the two groups. Results: A total of 210 patients were assigned to the bursectomy group (104 patients) and the nonbursectomy group (106 patients) between July 2002 and January 2007. Background characteristics were well balanced. Intraoperative blood loss was greater in the bursectomy group than in the nonbursectomy group (median 475 vs. 350 ml, p = 0.047), whereas other surgical factors did not vary significantly. The overall morbidity rate was 14.3{\%} (30 patients), the same for the two groups. Likewise, the incidence of major postoperative complications, including pancreatic fistula, anastomotic leakage, abdominal abscess, bowel obstruction, hemorrhage, and pneumonia, were not significantly different between the two groups. The medians of the amylase level of the drainage fluid on postoperative day 1 were similar for the two groups (median 282 vs. 314 IU/L, p = 0.543). The hospital mortality rate was 0.95{\%}: one patient per group. Conclusions: Experienced surgeons could safely perform a D2 gastrectomy with an additional bursectomy without increased major surgical complications.",
author = "Hiroshi Imamura and Yukinori Kurokawa and Junji Kawada and Toshimasa Tsujinaka and Shuji Takiguchi and Yoshiyuki Fujiwara and Masaki Mori and Yuichiro Doki",
year = "2011",
month = "3",
day = "1",
doi = "10.1007/s00268-010-0914-5",
language = "English",
volume = "35",
pages = "625--630",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer

T2 - Results of a randomized controlled trial

AU - Imamura, Hiroshi

AU - Kurokawa, Yukinori

AU - Kawada, Junji

AU - Tsujinaka, Toshimasa

AU - Takiguchi, Shuji

AU - Fujiwara, Yoshiyuki

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Background: Bursectomy, a procedure dissecting the peritoneal lining covering the pancreas and the anterior plane of the transverse mesocolon, has been commonly performed with radical gastrectomy for gastric cancer patients. Although possibly improving the prognosis of gastric cancers, adverse events related to bursectomy should be evaluated in prospective studies. Methods: This prospective randomized controlled trial was conducted by experienced surgeons in 11 Japanese institutions. Patients with T2 or T3 gastric adenocarcinoma were intraoperatively randomized to radical gastrectomy plus D2 lymphadenectomy either with or without bursectomy. Postoperative morbidity and mortality were compared between the two groups. Results: A total of 210 patients were assigned to the bursectomy group (104 patients) and the nonbursectomy group (106 patients) between July 2002 and January 2007. Background characteristics were well balanced. Intraoperative blood loss was greater in the bursectomy group than in the nonbursectomy group (median 475 vs. 350 ml, p = 0.047), whereas other surgical factors did not vary significantly. The overall morbidity rate was 14.3% (30 patients), the same for the two groups. Likewise, the incidence of major postoperative complications, including pancreatic fistula, anastomotic leakage, abdominal abscess, bowel obstruction, hemorrhage, and pneumonia, were not significantly different between the two groups. The medians of the amylase level of the drainage fluid on postoperative day 1 were similar for the two groups (median 282 vs. 314 IU/L, p = 0.543). The hospital mortality rate was 0.95%: one patient per group. Conclusions: Experienced surgeons could safely perform a D2 gastrectomy with an additional bursectomy without increased major surgical complications.

AB - Background: Bursectomy, a procedure dissecting the peritoneal lining covering the pancreas and the anterior plane of the transverse mesocolon, has been commonly performed with radical gastrectomy for gastric cancer patients. Although possibly improving the prognosis of gastric cancers, adverse events related to bursectomy should be evaluated in prospective studies. Methods: This prospective randomized controlled trial was conducted by experienced surgeons in 11 Japanese institutions. Patients with T2 or T3 gastric adenocarcinoma were intraoperatively randomized to radical gastrectomy plus D2 lymphadenectomy either with or without bursectomy. Postoperative morbidity and mortality were compared between the two groups. Results: A total of 210 patients were assigned to the bursectomy group (104 patients) and the nonbursectomy group (106 patients) between July 2002 and January 2007. Background characteristics were well balanced. Intraoperative blood loss was greater in the bursectomy group than in the nonbursectomy group (median 475 vs. 350 ml, p = 0.047), whereas other surgical factors did not vary significantly. The overall morbidity rate was 14.3% (30 patients), the same for the two groups. Likewise, the incidence of major postoperative complications, including pancreatic fistula, anastomotic leakage, abdominal abscess, bowel obstruction, hemorrhage, and pneumonia, were not significantly different between the two groups. The medians of the amylase level of the drainage fluid on postoperative day 1 were similar for the two groups (median 282 vs. 314 IU/L, p = 0.543). The hospital mortality rate was 0.95%: one patient per group. Conclusions: Experienced surgeons could safely perform a D2 gastrectomy with an additional bursectomy without increased major surgical complications.

UR - http://www.scopus.com/inward/record.url?scp=79952186531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952186531&partnerID=8YFLogxK

U2 - 10.1007/s00268-010-0914-5

DO - 10.1007/s00268-010-0914-5

M3 - Article

C2 - 21161652

AN - SCOPUS:79952186531

VL - 35

SP - 625

EP - 630

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 3

ER -